Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 39

Sort by

Sort Order Select

Journal Articles

Closing the circle for ETP ALL

Elaine Coustan-Smith, Valentino Conter

Blood (2023) 142 (24): 2039–2040.

https://doi.org/10.1182/blood.2023022072

Published: 2023

Journal Articles

Clofarabine-Based Chemotherapy for KMT2A r Infantile Acute Lymphoblastic Leukemia

Tanja Andrea Gruber, Deqing Pei, John Kim Choi, Cheng Cheng, Elaine Coustan-Smith, Dario Campana, Hope Swanson, Jennifer L Pauley, Hiroto Inaba, Monika Metzger, Jeffrey E. Rubnitz, Raul C Ribeiro, Susana C. Raimondi, William E. Evans, Mary V. Relling, Ching-Hon Pui, Sima Jeha

Blood (2021) 138 (Supplement 1): 3406.

https://doi.org/10.1182/blood-2021-148936

Published: 2021

Journal Articles

Reduced-intensity therapy for pediatric lymphoblastic leukemia: impact of residual disease early in remission induction

Iman Sidhom, Khaled Shaaban, Sarah H. Youssef, Nesreen Ali, Seham Gohar, Wafaa M. Rashed, Mai Mehanna, Sherine Salem, Sonya Soliman, Dina Yassin, Emad Mansour, Elaine Coustan-Smith, Raul C. Ribeiro, Gaston K. Rivera

Blood (2021) 137 (1): 20–28.

https://doi.org/10.1182/blood.2020007977

Published: 2021

Journal Articles

Reduced–dose intensity therapy for pediatric lymphoblastic leukemia: long-term results of the Recife RELLA05 pilot study

Francisco Pedrosa, Elaine Coustan-Smith, Yinmei Zhou, Cheng Cheng, Arli Pedrosa, Mecneide Mendes Lins, Marcia Pedrosa, Norma Lucena-Silva, Alessandra Maria de Luna Ramos, Ester Vinhas, Gaston K. Rivera, Dario Campana, Raul C. Ribeiro

Blood (2020) 135 (17): 1458–1466.

https://doi.org/10.1182/blood.2019004215

Published: 2020

Includes: Supplemental data

Journal Articles

Improved outcomes for myeloid leukemia of Down syndrome: a report from the Children’s Oncology Group AAML0431 trial

Jeffrey W. Taub, Jason N. Berman, Johann K. Hitzler, April D. Sorrell, Norman J. Lacayo, Kelley Mast, David Head, Susana Raimondi, Betsy Hirsch, Yubin Ge, Robert B. Gerbing, Yi-Cheng Wang, Todd A. Alonzo, Dario Campana, Elaine Coustan-Smith, Prasad Mathew, Alan S. Gamis

Blood (2017) 129 (25): 3304–3313.

https://doi.org/10.1182/blood-2017-01-764324

Published: 2017

Includes: Supplemental data

Journal Articles

A First-in-Human Study of Autologous T Lymphocytes with Antibody-Dependent Cell Cytotoxicity (ADCC) in Patients with B-Cell Non-Hodgkin Lymphoma (NHL)

Michelle Poon, Yeh Ching Linn, Noriko Shimasaki, Lip Kun Tan, Liang Piu Koh, Elaine Coustan-Smith, Dario Campana

Blood (2016) 128 (22): 3031.

https://doi.org/10.1182/blood.V128.22.3031.3031

Published: 2016

Journal Articles

Outcome of children with hypodiploid ALL treated with risk-directed therapy based on MRD levels

Blood (2015) 126 (26): 2896–2899.

https://doi.org/10.1182/blood-2015-09-671131

Published: 2015

Journal Articles

Improvement in Treatment Outcome and Identification of a New Prognostic Parameter in Down Syndrome Acute Myeloid Leukemia (DS-AML): Results of the Children’s Oncology Group (COG) Phase III AAML0431 Trial

Jeffrey W Taub, MD, Jason N Berman, MD, Johann K. Hitzler, MD, April D. Sorrell, MD, Norman J. Lacayo, MD, Kelley Mast, MD, David R. Head, MD, Susana C. Raimondi, PhD, Betsy A. Hirsch, PhD, Robert B. Gerbing, MA, Todd A. Alonzo, PhD, Dario Campana, MD PhD, Elaine Coustan-Smith, MS, Prasad Mathew, Alan S. Gamis, MD MPH

Blood (2014) 124 (21): 278.

https://doi.org/10.1182/blood.V124.21.278.278

Published: 2014

Journal Articles

Autonomous growth and increased cytotoxicity of natural killer cells expressing membrane-bound interleukin-15

Masaru Imamura, David Shook, Takahiro Kamiya, Noriko Shimasaki, Sally M. H. Chai, Elaine Coustan-Smith, Chihaya Imai, Dario Campana

Blood (2014) 124 (7): 1081–1088.

https://doi.org/10.1182/blood-2014-02-556837

Published: 2014

Includes: Supplemental data

Journal Articles

Prognostic Factors For Children With Acute Myeloid Leukemia Who Achieve Minimal Residual Disease-Negative Status After Induction Therapy

Seth E Karol, MD, Elaine Coustan-Smith, MS, Xueyuan Cao, PhD, Sheila A Shurtleff, PhD, Susana C Raimondi, PhD, John K Choi, MD, PhD, Raul C Ribeiro, MD, Gary V Dahl, MD, W Paul Bowman, MD, Jeffrey W Taub, MD, Barbara Degar, MD, Wing Leung, MD, PhD, James R Downing, MD, Ching-Hon Pui, MD, Jeffrey E Rubnitz, MD, PhD, Dario Campana, MD, PhD, Hiroto Inaba, MD, PhD

Blood (2013) 122 (21): 490.

https://doi.org/10.1182/blood.V122.21.490.490

Published: 2013

Journal Articles

Deep-sequencing approach for minimal residual disease detection in acute lymphoblastic leukemia

Malek Faham, Jianbiao Zheng, Martin Moorhead, Victoria E. H. Carlton, Patricia Stow, Elaine Coustan-Smith, Ching-Hon Pui, Dario Campana

Blood (2012) 120 (26): 5173–5180.

https://doi.org/10.1182/blood-2012-07-444042

Published: 2012

Includes: Supplemental data

Journal Articles

Deep Sequencing Approach for Minimal Residual Disease Detection in Acute Lymphoblastic Leukemia

Malek Faham, MD, PhD, Jianbiao Zheng, PhD, Martin Moorhead, PhD, Victoria Carlton, Patricia Lee Stow, BA, MS, Elaine Coustan-Smith, MS, Ching-Hon Pui, MD, Dario Campana, MD, PhD

Blood (2012) 120 (21): 1388.

https://doi.org/10.1182/blood.V120.21.1388.1388

Published: 2012

Journal Articles

Detectable minimal residual disease before hematopoietic cell transplantation is prognostic but does not preclude cure for children with very-high-risk leukemia

Blood (2012) 120 (2): 468–472.

https://doi.org/10.1182/blood-2012-02-409813

Published: 2012

Journal Articles

Discovery of Novel Recurrent Mutations in Childhood Early T-Cell Precursor Acute Lymphoblastic Leukemia by Whole Genome Sequencing - a Report From the St Jude Children's Research Hospital - Washington University Pediatric Cancer Genome Project

Jinghui Zhang, PhD, Li Ding, PhD, Linda Holmfeldt, PhD, Gang Wu, PhD, Susan L. Heatley, Ph.D., Debbie Payne-Turner, John Easton, PhD, Xiang Chen, PhD, Jianmin Wang, PhD, Michael Rusch, BA, Charles Lu, PhD, Shann-Ching Chen, PhD, Racquel Collins-Underwood, PhD, Jing Ma, PhD, Kathryn G. Roberts, PhD, Stanley Pounds, PhD, Lei Wei, PhD, Anatoly Ulyanov, PhD, Jared Becksfort, Pankaj Gupta, Robert Huether, PhD, Richard Kriwacki, PhD, Daniel McGoldrick, David Zhao, Daniel Alford, Stephen Espy, Kiran Chand Bobba, Guangchun Song, Deqing Pei, MS, Cheng Cheng, PhD, Stefan Roberts, Michael Barbato, Dario Campana, MD, PhD, Elaine Coustan-Smith, MS, William E. Evans, PharmD, Sheila A Shurtleff, PhD, Maria Kleppe, Jan Cools, PhD, Kristin Shimano, Michelle L. Hermiston, MD, PhD, Sergei Doulatov, PhD, Kolja Eppert, PhD, Elisa Laurenti, PhD, Faiyaz Notta, PhD, John E Dick, PhD, Giuseppe Basso, MD PhD, Stephen P. Hunger, MD, Mignon L Loh, MD, Meenakshi Devidas, PhD, Brent L. Wood, MD, PhD, Stuart S. Winter, MD, Kimberly Dunsmore, MD, Robert S. Fulton, MS, Lucinda A. Fulton, MS, Xin Hong, PhD, Christopher C. Harris, BS, David J. Dooling, PhD, Kerri Ochoa, Kimberly J Johnson, John C Obenauer, Ching-Hon Pui, MD, Susana C. Raimondi, PhD, Clayton W Naeve, PhD, Timothy J Ley, MD, Elaine R Mardis, PhD, Richard K Wilson, PhD, James R Downing, MD, Charles G Mullighan, MBBS, MD, FRACP, FRCPA, MSc

Blood (2011) 118 (21): 68.

https://doi.org/10.1182/blood.V118.21.68.68

Published: 2011

Journal Articles

Agammaglobulinemia associated with BCR − B cells and enhanced expression of CD19

A. Kerry Dobbs, Amma Bosompem, Elaine Coustan-Smith, Gayle Tyerman, Frank T. Saulsbury, Mary Ellen Conley

Blood (2011) 118 (7): 1828–1837.

https://doi.org/10.1182/blood-2011-01-330472

Published: 2011

Includes: Supplemental data

Journal Articles

High success rate of hematopoietic cell transplantation regardless of donor source in children with very high-risk leukemia

Wing Leung, Dario Campana, Jie Yang, Deqing Pei, Elaine Coustan-Smith, Kwan Gan, Jeffrey E. Rubnitz, John T. Sandlund, Raul C. Ribeiro, Ashok Srinivasan, Christine Hartford, Brandon M. Triplett, Mari Dallas, Asha Pillai, Rupert Handgretinger, Joseph H. Laver, Ching-Hon Pui

Blood (2011) 118 (2): 223–230.

https://doi.org/10.1182/blood-2011-01-333070

Published: 2011

Includes: Supplemental data

Journal Articles

New markers for minimal residual disease detection in acute lymphoblastic leukemia

Elaine Coustan-Smith, Guangchun Song, Christopher Clark, Laura Key, Peixin Liu, Mohammad Mehrpooya, Patricia Stow, Xiaoping Su, Sheila Shurtleff, Ching-Hon Pui, James R. Downing, Dario Campana

Blood (2011) 117 (23): 6267–6276.

https://doi.org/10.1182/blood-2010-12-324004

Published: 2011

Includes: Supplemental data

Journal Articles

Improved Prognosis for Older Adolescents with Acute Lymphoblastic Leukemia

Blood (2010) 116 (21): 498.

https://doi.org/10.1182/blood.V116.21.498.498

Published: 2010

Journal Articles

Excellent Outcome for ETV6/RUNX1 -Positive Childhood Acute Lymphoblastic Leukemia (ALL) with Contemporary Therapy

Blood (2010) 116 (21): 495.

https://doi.org/10.1182/blood.V116.21.495.495

Published: 2010

Journal Articles

Clinical Activity, Pharmacokinetics, and Pharmacodynamics of Sorafenib In Pediatric Acute Myeloid Leukemia.

Hiroto Inaba, MD, PhD, Jeffrey E Rubnitz, MD, PhD, Elaine Coustan-Smith, MS, Lie Li, Brian D Furmanski, PhD, Gerard P Mascara, Sheila A Shurtleff, PhD, Stanley B Pounds, PhD, Ching-Hon Pui, MD, Raul C Ribeiro, MD, Dario Campana, MD, PhD, Sharyn D Baker, PharmD, PhD

Blood (2010) 116 (21): 1073.

https://doi.org/10.1182/blood.V116.21.1073.1073

Published: 2010

NARROW

Closing the circle for ETP ALL

Clofarabine-Based Chemotherapy for KMT2A r Infantile Acute Lymphoblastic Leukemia

Reduced-intensity therapy for pediatric lymphoblastic leukemia: impact of residual disease early in remission induction

Reduced–dose intensity therapy for pediatric lymphoblastic leukemia: long-term results of the Recife RELLA05 pilot study

Improved outcomes for myeloid leukemia of Down syndrome: a report from the Children’s Oncology Group AAML0431 trial

A First-in-Human Study of Autologous T Lymphocytes with Antibody-Dependent Cell Cytotoxicity (ADCC) in Patients with B-Cell Non-Hodgkin Lymphoma (NHL)

Outcome of children with hypodiploid ALL treated with risk-directed therapy based on MRD levels

Improvement in Treatment Outcome and Identification of a New Prognostic Parameter in Down Syndrome Acute Myeloid Leukemia (DS-AML): Results of the Children’s Oncology Group (COG) Phase III AAML0431 Trial

Autonomous growth and increased cytotoxicity of natural killer cells expressing membrane-bound interleukin-15

Prognostic Factors For Children With Acute Myeloid Leukemia Who Achieve Minimal Residual Disease-Negative Status After Induction Therapy

Deep-sequencing approach for minimal residual disease detection in acute lymphoblastic leukemia

Deep Sequencing Approach for Minimal Residual Disease Detection in Acute Lymphoblastic Leukemia

Detectable minimal residual disease before hematopoietic cell transplantation is prognostic but does not preclude cure for children with very-high-risk leukemia

Discovery of Novel Recurrent Mutations in Childhood Early T-Cell Precursor Acute Lymphoblastic Leukemia by Whole Genome Sequencing - a Report From the St Jude Children's Research Hospital - Washington University Pediatric Cancer Genome Project

Agammaglobulinemia associated with BCR − B cells and enhanced expression of CD19

High success rate of hematopoietic cell transplantation regardless of donor source in children with very high-risk leukemia

New markers for minimal residual disease detection in acute lymphoblastic leukemia

Improved Prognosis for Older Adolescents with Acute Lymphoblastic Leukemia

Excellent Outcome for ETV6/RUNX1 -Positive Childhood Acute Lymphoblastic Leukemia (ALL) with Contemporary Therapy

Clinical Activity, Pharmacokinetics, and Pharmacodynamics of Sorafenib In Pediatric Acute Myeloid Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only